SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer
Virdee PS., Shaw R., Strauss VY., Hamill C., Hurt CN., Corrie P., Bridgewater J., Parsons P., Tranter B., Sebag-Montefiore D., Chu K., Radhakrishna G., Hawkins M., O’Neill E., Campbell S., Love SB., Maughan T., Mukherjee S.